Skip to main content

Table 3 Summary of the characteristics of included studies reviewed

From: Factors influencing breast cancer screening practices among women worldwide: a systematic review of observational and qualitative studies

Author, Year

Study design

Data source

Country

Sampling method

Sample size

Participants and age of participants

Screening method and Screening participation rate

Conceptual framework

MQS

Safarpour et al., 2018 [24]

Cross-sectional

Questionnaire

Iran

Simple Random

304

Women 20–65

BCS (BSE or CBE):17.1%

Knowledge-Attitude Practice Model

15

Moreira et al., 2018 [38]

Cross-sectional

Questionnaire

Brazil

Convenient

40

Women 50–69

MMG: Not Reported

Health Belief Model

12

Dewi et al., 2019 [33]

Cross-sectional

Questionnaire

Indonesia

Multistage, Stratified

And Cluster, Random

1967

Women 20–60

BSE: 44.4%

Health Belief Model

15

Fouladi et al., 2013 [35]

Cross sectional

Questionnaire

Iran

Convenient

380

Women ≥ 30

BSE: 27%

MMG: 6.8%

Health Belief Model

14

Canbulat and Uzun, 2008 [31]

Cross-sectional

Questionnaire

Turkey

Stratified

And Systematic

268

Women ≥ 20

BSE: 21.9%

MMG: 12.5%

Health Belief Model

14

Ahmad and Stewart, 2004 [39]

Cross-sectional

Questionnaire

Canada

Convenient

54

Women 25–60

CBE: 38.5%

Health Belief Model

11

Harirchi et al., 2012 [37]

Cross-sectional

Questionnaire

Iran

Stratified Simple-Random

770

Women ≥ 30

BSE: 36.6%

CBE:17.4%

MMG: 6.4%

Knowledge-Attitude Practice Model

13

Kardan-Souraki et al., 2019 [20]

Cross sectional

Questionnaire

Iran

Cluster

1165

Women ≥ 30

BSE: 62%

CBE:41.1%

MMG: 21.7%

None

13

Bailly et al., 2023 [44]

Cross-sectional

Statistical information units

France

Stratified Random

144

Women 50–74

MMG: 54-56%

None

11

Hajian-Tilaki and Auladi, 2014 [36]

Cross-sectional

Questionnaire

Interview

Iran

Cluster

500

Women 18–65

BSE: 38.4

CBE:25.2%

MMG: 12%

Health Belief Model

16

Tavafian et al., 2009 [28]

Cross-sectional

Questionnaire

Iran

Cluster

240

Women ≥ 30

BSE: 31.7%

Health Belief Model

15

Ahmadian et al., 2016 [47]

Cross-sectional

Questionnaire

Malaysia

Multistage Cluster Random

842

Women 17–52

BSE: NOT REPORTED

Health Belief Model

15

Jin et al., 2019 [16]

Cross-sectional

Questionnaire

USA

Purposive

303

Women 50–80

MMG: 73.3%

Andersen’s Behavioral Model

14

Charkazi et al., 2013 [32]

Cross-sectional

Questionnaire

Iran

Cluster

1080

Women 30–82

BSE: 13.1%

CBE: 2.5%

MMG:0.9%

Health Belief Model

13

Marmarà et al., 2017 [42]

Cross sectional

Questionnaire

Malta

Stratified Random

404

Women 50–60

MMG: NOT REPORTED

Health Belief Model

&

Common-Sense Model

16

Kangmennaang et al., 2019 [45]

Cross-sectional

Questionnaire

Interview

Namibia

Cluster

9176

Women 15–64

BSE:35%

Health Belief Model

14

Secginli and Nahcivan, 2006 [25]

Cross-sectional

Questionnaire

Turkey

Convenience

656

Women ≥ 20

BSE: 17%

MMG:25%

Health Belief Model

13

Racine et al., 2022 [41]

Cross-sectional

Questionnaire

Canada

Convenience

75

Women ≥ 18

BSE: 32%

CBE: 12%

MMG: 6.7%

Health Belief Model

14

Ma et al., 2012 [40]

Cross-sectional

Questionnaire

USA

Cluster Random

&

Proportional

682

Women ≥ 40

MMG: 50.04%

Sociocultural Health Behavior Model

13

Shakor et al., 2019 [26]

Cross-sectional

Questionnaire

Iraq

Non-Probability (Purposive)

750

Women ≥ 20

BSE: 18.0%

Health Belief Model

15

Thomas et al., 2011 [29]

Qualitative

Interview

Iran

Quota

31

Women 35–65

BCS: Not Reported

None

11

Hassan et al., 2017 [12]

Cross-sectional

Questionnaire

Interview

Egypt

Systematic Random

600

Women ≥ 20

BSE: 0.3%

MMG: 0.3%

None

12

Khazaee-pool et al., 2014 [48]

Qualitative

Interview

Iran

Purposive

16

Women ≥ 30

MMG: Not Reported

None

12

Moghaddam et al., 2019 [22]

Cross-sectional

Questionnaire

Iran

Multi-Stage Random

192

Women ≥ 30

BSE: 14%

CBE:22.9%

MMG: 10.1%

Pen-3 Model

14

Çam and Gümüs, 2009 [30]

Cross-sectional

Questionnaire

Turkey

Stratified Random

382

Women ≥ 40

BSE: 59.4%

CBE:14.1%

MMG: 34%

Health Belief Model

14

Moh Myint et al., 2020 [23]

Qualitative

Interview

Myanmar

Purposive

8

Women 20–45

BSE: Not Reported

None

11

Donnelly et al., 2017 [34]

Qualitative

Interview

Qatar

Purposive

50

Men 30–55

BCS: Not Reported

Ecological Perspective

Klein Man’s Explanatory Model

13

Abeje et al., 2019 [13]

Cross-sectional

Questionnaire

Ethiopia

Multi-Stage Random

633

Women 20–49

BSE: 24.3%

CBE:7.6%

MMG: 3.8%

None

11

Carey and El-Zaemey, 2020 [15]

Cross-sectional

Questionnaire

Australia

Simple Random

1705

Women ≥ 40

MMG: 88.1%

None

11

Parsa and Kandiah, 2010 [11]

Cross-sectional

Questionnaire

Malaysia

Multi-Stage Random

425

Women 23–56

CBE:25%

MMG: 13.6%

Health Belief Model

14

Tabrizi et al., 2018 [27]

Cross-sectional

Questionnaire

Iran

Multi-Stage Random

348

Women 30–60

MMG: 12%

None

12

Schoofs et al., 2017 [14]

Cross-sectional

Questionnaire

Belgium

Quota

350

Women 50–69

MMG: 81.5%

None

11

Lagerlund et al., 2015 [43]

cohort

Questionnaire

Sweden

Simple Random

11 409

Women 40–74

MMG: 88–95%

None

14

Elewonibi and BeLue, 2019 [46]

Qualitative

Interview

Nigeria

Convenience

94

Women ≥ 18

BCS: Not Reported

Pen-3 Model

12

  1. Abbreviations: BCS Breast cancer screening, BSE Breast self-examination, CBE Clinical breast examination, MMG Mammography, MQS Methodological quality score